How Estrogen Affects Breast Cancer Growth
Author Information
Author(s): He Chongwu, Peng Meixi, Zeng Xiaoqiang, Dong Hanzhi, Sun Zhengkui, Xu Jiawei, Liu Manran, Liu Liyan, Huang Yanxiao, Peng Zhiqiang, Qiu Yu-An, Jiang Chunling, Xu Bin, Yu Tenghua
Primary Institution: Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College
Hypothesis
This study investigates how GPER influences the metabolic interaction between cancer-associated fibroblasts and triple-negative breast cancer cells.
Conclusion
Targeting the estrogen/GPER/glutamine signaling axis in cancer-associated fibroblasts offers a promising therapeutic strategy to inhibit triple-negative breast cancer progression.
Supporting Evidence
- Estrogen-activated GPER in CAFs enhances GLUL and LDHB expression via the cAMP/PKA/CREB signaling.
- Microenvironmental GPER-induced glutamine serves as a crucial mediator of metabolic coupling between CAFs and TNBC cells.
- Targeting the glutamine metabolic coupling triggered by estrogen/GPER/GLUL signaling in CAFs is a promising therapeutic strategy for TNBC treatment.
Takeaway
This study shows that a special receptor activated by estrogen helps cancer cells get the nutrients they need to grow, which could be a target for new treatments.
Methodology
The study used a co-culture system to examine the interaction between cancer-associated fibroblasts and triple-negative breast cancer cells, focusing on glutamine production and signaling pathways.
Limitations
The study does not explore the biological functions of more detailed CAF subgroups such as matrix CAFs or inflammatory CAFs.
Participant Demographics
130 patients with triple-negative breast cancer from Jiangxi Cancer Hospital.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website